Compile Data Set for Download or QSAR
Found 109 Enz. Inhib. hit(s) with all data for entry = 50026599
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263229(3-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(4...)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263230(3-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(2...)copy SMILEScopy InChI
Affinity DataIC50: 0.0300nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50245187(3-(4-(1-(3-ethoxyphenyl)-2-(2-fluoro-4-methylpheny...)copy SMILEScopy InChI
Affinity DataIC50: 0.0600nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263227(3-(4-(2-(2,4-difluorophenyl)-1-(3-ethoxyphenyl)-1H...)copy SMILEScopy InChI
Affinity DataIC50: 0.0700nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263226(3-(4-(1-(3-ethoxyphenyl)-2-(4-fluorophenyl)-1H-imi...)copy SMILEScopy InChI
Affinity DataIC50: 0.0800nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263225((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(4-fluo...)copy SMILEScopy InChI
Affinity DataIC50: 0.120nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50245180(3-(4-(1-(3-ethoxyphenyl)-2-p-tolyl-1H-imidazole-4-...)copy SMILEScopy InChI
Affinity DataIC50: 0.120nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262862(3-(4-(1-(3-methoxyphenyl)-2-p-tolyl-1H-imidazole-4...)copy SMILEScopy InChI
Affinity DataIC50: 0.140nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263228(3-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-p-...)copy SMILEScopy InChI
Affinity DataIC50: 0.140nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263186((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-p-tolyl...)copy SMILEScopy InChI
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263185((1-(3-ethoxyphenyl)-2-(2-fluoro-4-methylphenyl)-1H...)copy SMILEScopy InChI
Affinity DataIC50: 0.240nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262973((1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-p-tolyl...)copy SMILEScopy InChI
Affinity DataIC50: 0.420nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50245193((1-(3-ethoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4-...)copy SMILEScopy InChI
Affinity DataIC50: 0.450nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263139((1-(3-ethoxyphenyl)-2-(2-fluoro-4-methylphenyl)-1H...)copy SMILEScopy InChI
Affinity DataIC50: 0.560nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263184((1-(3-ethoxyphenyl)-2-(2-fluorophenyl)-1H-imidazol...)copy SMILEScopy InChI
Affinity DataIC50: 0.570nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263140((1-(3-ethoxyphenyl)-2-(4-fluorophenyl)-1H-imidazol...)copy SMILEScopy InChI
Affinity DataIC50: 0.600nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263104((2-(2,4-difluorophenyl)-1-(3-ethoxyphenyl)-1H-imid...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262817((1-(3-methoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4...)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262861(3-(4-(1-(3-methoxyphenyl)-2-p-tolyl-1H-imidazole-4...)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263103((2-(2,6-difluorophenyl)-1-(3-ethoxyphenyl)-1H-imid...)copy SMILEScopy InChI
Affinity DataIC50: 1.90nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263102((1-(3-ethoxyphenyl)-2-(2-fluorophenyl)-1H-imidazol...)copy SMILEScopy InChI
Affinity DataIC50: 1.90nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262816((4-(isoquinolin-3-yl)piperazin-1-yl)(1-(3-methoxyp...)copy SMILEScopy InChI
Affinity DataIC50: 1.90nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263061((1-(3-ethoxyphenyl)-2-(4-fluorophenyl)-1H-imidazol...)copy SMILEScopy InChI
Affinity DataIC50: 1.90nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262914((1-(3-ethoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4-...)copy SMILEScopy InChI
Affinity DataIC50: 2.30nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262776((1-(3-methoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4...)copy SMILEScopy InChI
Affinity DataIC50: 2.5nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263019((1-(3-ethoxyphenyl)-2-phenyl-1H-imidazol-4-yl)(4-(...)copy SMILEScopy InChI
Affinity DataIC50: 3.40nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263062((2-(4-chlorophenyl)-1-(3-ethoxyphenyl)-1H-imidazol...)copy SMILEScopy InChI
Affinity DataIC50: 5.60nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262863((1-(4-methoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4...)copy SMILEScopy InChI
Affinity DataIC50: 6.90nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262672((4-(3,4-dichlorophenyl)piperazin-1-yl)(1-(3-methox...)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262859((1-(3-methoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4...)copy SMILEScopy InChI
Affinity DataIC50: 8.60nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262613((4-(3-chlorophenyl)piperazin-1-yl)(1-(3-methoxyphe...)copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262815((1-(3-methoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4...)copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262778((4-(1H-benzo[d]imidazol-2-yl)piperazin-1-yl)(1-(3-...)copy SMILEScopy InChI
Affinity DataIC50: 17nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262913((1-(3-hydroxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4...)copy SMILEScopy InChI
Affinity DataIC50: 22nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262970((1-(3-isopropoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl...)copy SMILEScopy InChI
Affinity DataIC50: 30nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263063((1-(3-ethoxyphenyl)-2-(3-fluorophenyl)-1H-imidazol...)copy SMILEScopy InChI
Affinity DataIC50: 35nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263237((4-(3-chlorophenyl)piperazin-1-yl)(5-(3-methoxyphe...)copy SMILEScopy InChI
Affinity DataIC50: 41nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262912((1-(3-ethylphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4-(...)copy SMILEScopy InChI
Affinity DataIC50: 43nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263020((1-(3-ethoxyphenyl)-2-(4-ethylphenyl)-1H-imidazol-...)copy SMILEScopy InChI
Affinity DataIC50: 43nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262971((4-(naphthalen-2-yl)piperazin-1-yl)(2-p-tolyl-1-(3...)copy SMILEScopy InChI
Affinity DataIC50: 130nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263018((1-(2,3-dihydrobenzo[b][1,4]dioxin-5-yl)-2-p-tolyl...)copy SMILEScopy InChI
Affinity DataIC50: 140nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262969((4-(naphthalen-2-yl)piperazin-1-yl)(1-(3-propoxyph...)copy SMILEScopy InChI
Affinity DataIC50: 160nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262860((4-(isoquinolin-6-yl)piperazin-1-yl)(1-(3-methoxyp...)copy SMILEScopy InChI
Affinity DataIC50: 190nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262972((4-(naphthalen-2-yl)piperazin-1-yl)(2-p-tolyl-1-(3...)copy SMILEScopy InChI
Affinity DataIC50: 200nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262777((1-(3-methoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4...)copy SMILEScopy InChI
Affinity DataIC50: 630nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263229(3-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(4...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CCK2 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263230(3-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-(2...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CCK2 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50245193((1-(3-ethoxyphenyl)-2-p-tolyl-1H-imidazol-4-yl)(4-...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CCK2 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263228(3-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-p-...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CCK2 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50263227(3-(4-(2-(2,4-difluorophenyl)-1-(3-ethoxyphenyl)-1H...)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CCK2 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2HH6JW0PubMed
Displayed 1 to 50 (of 109 total ) | Next | Last >>
Jump to: